Surfing the NASH Tsunami Podcast Artwork Image

Surfing the NASH Tsunami

HEP Dynamics LLC

Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the NASH Tsunami podcast. #NASH #NAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL
Improving NASH Clinical Trials By Reducing Screen Fail Rates August 17, 2022 Episode artwork S3-E40.5 - From the Vault: Why Cirrhosis Matters In Clinical Trial StrategyAugust 14, 2022 Episode artwork S3-E40.4 - Challenges of Alcohol Screening in Fatty Liver DiseaseAugust 14, 2022 Episode artwork S3-E40.3 - Importance of Early Diagnosis in Lean NASHAugust 13, 2022 Episode artwork S3-E40.2 - A Simple Diagnostic Algorithm for Lean NASHAugust 13, 2022 Episode artwork S3-E40.1 - Best Practices in Lean NASH: How the Article Came About August 13, 2022 Episode artwork S3-E40 - Best Practices in Lean NASH -- Authors Provide Back StoryAugust 10, 2022 Episode artwork S3-E39.5 - From The Vault: Early, Accurate Patient Information Matters August 07, 2022 Episode artwork S3-E39.4 - Patient Follow-Up Challenges in Modeling NASH Diagnostics August 07, 2022 Episode artwork S3-E39.3 - NASH challenges: Early Diagnosis and NASH Patient ManagementAugust 06, 2022 Episode artwork S3-E39.2 - What An Early Decision Models Tells Us About Fibrosis & Metabolic DiseasesAugust 06, 2022 Episode artwork S3-E39.1 - Creating An Early Diagnosis NASH Decision Model August 06, 2022 Episode artwork S3-E39 - Reviewing a Decision Model for Early NASH DiagnosisAugust 03, 2022 Episode artwork S3-E38.8 - From the Vault: Discussing Patient empowerment at INCBCN 2022July 31, 2022 Episode artwork S3-E38.7 - From the Vault: How Ballooned hepatocyte Reads Affect NASH Clinical TrialsJuly 31, 2022 Episode artwork S3-E38.6 - From the Vault: Patient-Focused Drug Development from Global Liver InstituteJuly 31, 2022 Episode artwork S3-E38.5 - From the Vault: NAIL-NIT tackles NAS Score ChallengesJuly 30, 2022 Episode artwork S3-E38.4 - From the Vault: NITs & Advancing NASH Therapy at AASLD 2021July 30, 2022 Episode artwork S3-E38.3 - From the Vault: Learning About Stellate Cells and Fibrosis at Paris NASHJuly 30, 2022 Episode artwork S3-E38.2 - From the Vault: Scott Friedman on Fibrosis and Precision MedicineJuly 30, 2022 Episode artwork S3-E38.1 - From the Vault: Why NASH Drug Trials FailJuly 28, 2022 Episode artwork S3-E38 - SurfingNASH 2nd Anniversary: Buzzsprout, Download Barriers and More!July 27, 2022 Episode artwork S3-E37.5 - The Need to Focus on NASH Cirrhosis Patients July 24, 2022 Episode artwork S3-E37.4 - The "Pincer Movement" In Cirrhosis Technology: Patient Support vs High-End MedTechJuly 24, 2022 Episode artwork S3-E37.3 - Where Is The Next Cirrhosis Breakthrough?July 23, 2022 Episode artwork